The Need for Pharmacoeconomic Evaluations in the NHS John P. Griffin Current Opinion 28 November 2012 Pages: 241 - 250
Methodological Quality of Economic Modelling Studies Tom JeffersonVittorio Demicheli Current Opinion 28 November 2012 Pages: 251 - 257
Reporting Format for Economic Evaluation Mark J. C. NuijtenMarja H. PronkAry van der Kuy Leading Article 28 November 2012 Pages: 259 - 268
Outcomes of Pharmacological and Surgical Treatment for Obesity Jennifer CerulliMargaret Malone Review Article 28 November 2012 Pages: 269 - 283
Cost Analysis of Palliative Care for Terminally Ill Cancer Patients in the UK After Switching from Weak to Strong Opioids Julian F. GuestWarren M. HartRonald F. Cookson Original Research Article 28 November 2012 Pages: 285 - 297
The Economic Impact of Parkinson’s Disease Richard C. DodelMarikka SingerWolfgang H. Oertel Original Research Article 28 November 2012 Pages: 299 - 312
Cost Effectiveness of Immunoprophylaxis in the Prevention of Recurrent Infectious Rhinitis in Adults Gilles BerdeauxAntoine LafumaFrancis Fagnani Original Research Article 28 November 2012 Pages: 313 - 322
Costs and Effects Associated with a Community Pharmacy-Based Smoking-Cessation Programme Grainne E. CrealeyJames C. McElnayCiaran O’Neill Original Research Article 28 November 2012 Pages: 323 - 333
Methodological Quality of Economic Modelling Studies Michelle Wilde Correspondence 28 November 2012 Pages: 335 - 335